Inspire Investing
AGIO icon

Inspire Investing’s Agios Pharmaceuticals AGIO Stock Holding History

Inspire Investing’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$636K Buy
19,130
+861
+5% +$30.1K 0.03% 686
2026
Q2 		$678K Buy
18,269
+3,529
+24% +$107K 0.03% 774
2026
Q1 		$499K Sell
14,740
-2,375
-14% -$67.3K 0.03% 841
2025
Q4 		$466K Buy
17,115
+5,720
+50% +$201K 0.04% 653
2025
Q3 		$457K Sell
11,395
-333
-3% -$12.5K 0.04% 421
2025
Q2 		$390K Sell
11,728
-40
-0.3% -$1.21K 0.04% 520
2025
Q1 		$345K Sell
11,768
-616
-5% -$20.4K 0.04% 452
2024
Q4 		$407K Buy
12,384
+3,156
+34% +$148K 0.05% 367
2024
Q3 		$410K Buy
9,228
+1,113
+14% +$50.5K 0.04% 706
2024
Q2 		$350K Sell
8,115
-4,087
-33% -$148K 0.04% 666
2024
Q1 		$357K Sell
12,202
-5,011
-29% -$134K 0.04% 712
2023
Q4 		$383K Buy
17,213
+4,869
+39% +$109K 0.04% 607
2023
Q3 		$306K Buy
12,344
+1,327
+12% +$35.1K 0.04% 711
2023
Q2 		$312K Sell
11,017
-826
-7% -$20.6K 0.04% 752
2023
Q1 		$272K Buy
11,843
+3,366
+40% +$89.4K 0.03% 689
2022
Q4 		$238K Buy
8,477
+1,199
+16% +$33.8K 0.03% 374
2022
Q3 		$206K Buy
+7,278
New +$195K 0.03% 585

Other funds holding AGIO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Inspire Investing's AGIO Position: Q3 2026 in Review

Inspire Investing increased its Agios Pharmaceuticals (AGIO) stake by 4.7% in Q3 2026, buying an estimated $30.1K and bringing the position to 19,130 shares worth $636K. The position accounts for 0.03% of the portfolio, ranked #686.

Inspire Investing first reported a position in AGIO in Q3 2022 and has held it in 17 quarters since. The position peaked at $678K in Q2 2026. 175 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Inspire Investing held 19,130 shares of Agios Pharmaceuticals worth $636K as of Q3 2026.
  • Inspire Investing bought 861 Agios Pharmaceuticals shares in Q3 2026, an estimated $30.1K.
  • Agios Pharmaceuticals made up 0.03% of Inspire Investing's portfolio in Q3 2026, its #686 holding.
  • Inspire Investing first reported a position in Agios Pharmaceuticals in Q3 2022 and has held it in 17 quarters since.
  • Inspire Investing's Agios Pharmaceuticals position peaked at $678K in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.